A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model

References

• Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One 2015; 10:e114989; PMID:25608026; https://doi.org/10.1371/journal.pone.0140765 10.1371/journal.pone.0114989 10.1371/journal.pone.0128615
   PubMed Web of Science ®Google Scholar
• Wald A. Genital HSV-1 infections. Sex Transm Infect 2006; 82:189-90; PMID:16731663; https://doi.org/10.1136/sti.2006.019935
   PubMed Web of Science ®Google Scholar
• Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Annals of internal medicine 1994; 121:847-54; PMID:7978697; https://doi.org/10.7326/0003-4819-121-11-199412010-00004
   PubMed Web of Science ®Google Scholar
• Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007; 370:2127-37; PMID:18156035; https://doi.org/10.1016/S0140-6736(07)61908-4
   PubMed Web of Science ®Google Scholar
• Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98:958-72; PMID:6344712; https://doi.org/10.7326/0003-4819-98-6-958 10.7326/0003-4819-98-6-914
   PubMed Web of Science ®Google Scholar
• Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. Jama 2011; 305:1441-9; PMID:21486977; https://doi.org/10.1001/jama.2011.420
   PubMed Web of Science ®Google Scholar
• Tedder DG, Ashley R, Tyler KL, Levin MJ. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med 1994; 121:334-8; PMID:8042822; https://doi.org/10.7326/0003-4819-121-5-199409010-00004
   PubMed Web of Science ®Google Scholar
• Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, Watts DH, Berry S, Herd M, Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337:509-15; PMID:9262493; https://doi.org/10.1056/NEJM199712253372618 10.1056/NEJM199708213370801
   PubMed Web of Science ®Google Scholar
• Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004; 35:435-45; PMID:15021308; https://doi.org/10.1097/00126334-200404150-00001
   PubMed Web of Science ®Google Scholar
• Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, Kamb M, Wald A. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Archives of internal medicine 2009; 169:1233-40; PMID:19597073; https://doi.org/10.1001/archinternmed.2008.545 10.1001/archinternmed.2009.177
   PubMed Web of Science ®Google Scholar
• Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, Charvat B, Ssempijja V, Riedesel M, Oliver AE, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298-309; PMID:19321868; https://doi.org/10.1056/NEJMoa0802556
   PubMed Web of Science ®Google Scholar
• Freeman EE, White RG, Bakker R, Orroth KK, Weiss HA, Buve A, Hayes RJ, Glynn JR. Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa. Vaccine 2009; 27:940-6; PMID:19071187; https://doi.org/10.1016/j.vaccine.2008.11.074
   PubMed Web of Science ®Google Scholar
• Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM Jr, Paavonen J, Morrow RA, Beutner KR, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.[see comment]. New England Journal of Medicine 2004; 350:11-20; PMID:14702423; https://doi.org/10.1056/ENEJMicm020035 10.1056/NEJMoa035144
   PubMed Web of Science ®Google Scholar
• Reitano M, Tyring S, Lang W, Thoming C, Worm AM, Borelli S, Chambers LO, Robinson JM, Corey L. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group. J Infect Dis 1998; 178:603-10.
   PubMed Web of Science ®Google Scholar
• Skoberne M, Cardin R, Lee A, Kazimirova A, Zielinski V, Garvie D, Lundberg A, Larson S, Bravo FJ, Bernstein DI, et al. An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs. J Virol 2013; 87:3930-42; PMID:23365421; https://doi.org/10.1128/JVI.02745-12
   PubMed Web of Science ®Google Scholar
• Yim KC, Carroll CJ, Tuyama A, Cheshenko N, Carlucci MJ, Porter DD, Prince GA, Herold BC. The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies. J Virol 2005; 79:14632-9; PMID:16282463; https://doi.org/10.1128/JVI.79.23.14632-14639.2005
   PubMed Web of Science ®Google Scholar
• Boukhvalova M, McKay J, Mbaye A, Sanford-Crane H, Blanco JC, Huber A, Herold BC. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model. J Virol 2015; 89:9825-40; PMID:26178984; https://doi.org/10.1128/JVI.01387-15
   PubMed Web of Science ®Google Scholar
• Stanberry LR, Kern ER, Richards JT, Abbott TM, Overall JC, Jr. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis 1982; 146:397-404; PMID:6286797; https://doi.org/10.1093/infdis/146.3.397
   PubMed Web of Science ®Google Scholar
• Awasthi S, Huang J, Shaw C, Friedman HM. Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes. J Virol 2014; 88:8421-32; PMID:24829358; https://doi.org/10.1128/JVI.03163-13 10.1128/JVI.01130-14
   PubMed Web of Science ®Google Scholar
• Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, Margolis TP. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A 2002; 99:978-83; PMID:11773630; https://doi.org/10.1073/pnas.022301899
   PubMed Web of Science ®Google Scholar
• Awasthi S, Hook LM, Shaw CE, Pahar B, Stagray JA, Liu D, Veazey RS, Friedman HM. An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. PLoS Pathog 2017; 13:e1006141; PMID:28103319; https://doi.org/10.1371/journal.ppat.1006141
   PubMed Web of Science ®Google Scholar
• Eisenberg RJ, Atanasiu D, Cairns TM, Gallagher JR, Krummenacher C, Cohen GH. Herpes virus fusion and entry: a story with many characters. Viruses 2012; 4:800-32; PMID:22754650; https://doi.org/10.3390/v4050800
   PubMed Web of Science ®Google Scholar
• Awasthi S, Lubinski JM, Shaw CE, Barrett SM, Cai M, Wang F, Betts M, Kingsley S, Distefano DJ, Balliet JW, et al. Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone. J Virol 2011; 85:10472-86; PMID:21813597; https://doi.org/10.1128/JVI.00849-11
   PubMed Web of Science ®Google Scholar
• Phipps W, Saracino M, Magaret A, Selke S, Remington M, Huang ML, Warren T, Casper C, Corey L. Persistent genital herpes simplex virus-2 shedding years following the first clinical episode. J Infect Dis 2011; 203:180-7; PMID:21288817; https://doi.org/10.1093/infdis/jiq035
   PubMed Web of Science ®Google Scholar
• Douglas JM, Critchlow C, Benedetti J, Mertz GJ, Connor JD, Hintz MA, Fahnlander A, Remington M, Winter C, Corey L. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984; 310:1551-6; PMID:6328298; https://doi.org/10.1056/NEJM198406143102402
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Farley N, Bravo FJ, Earwood J, McNeal M, Fairman J, Cardin R. The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs. Vaccine 2010; 28:3748-53; PMID:19857450; https://doi.org/10.1016/j.vaccine.2009.10.025
   PubMed Web of Science ®Google Scholar
• Cohen JI. Vaccination to reduce reactivation of herpes simplex virus 2. J Infect Dis 2017; 215:844-6.
   Web of Science ®Google Scholar
• Awasthi S, Friedman HM. Status of prophylactic and therapeutic genital herpes vaccines. Curr Opin Virol 2014; 6:6-12; PMID:24631871; https://doi.org/10.1016/j.coviro.2014.02.006
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Wald A, Warren T, Fife K, Tyring S, Lee P, Van Wagoner N, Magaret A, Flechtner JB, Tasker S, et al. Therapeutic vaccine for genital herpes simplex virus-2 infection: Findings from a randomized trial. J Infect Dis 2017; PMID:28329211; https://doi.org/10.1093/infdis/jix004
   PubMed Web of Science ®Google Scholar
• Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52; PMID:11756980; https://doi.org/10.1086/338231
   PubMed Web of Science ®Google Scholar
• Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-19; PMID:18572080; https://doi.org/10.1016/S0140-6736(08)60920-4
   PubMed Web of Science ®Google Scholar
• Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-39; PMID:20089951; https://doi.org/10.1056/NEJMoa0904849
   PubMed Web of Science ®Google Scholar
• Freeman EE, Orroth KK, White RG, Glynn JR, Bakker R, Boily MC, Habbema D, Buvé A, Hayes R. Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect 2007; 83 Suppl 1:i17-24; PMID:17405782; https://doi.org/10.1136/sti.2006.023549
   PubMed Web of Science ®Google Scholar
• Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. Aids 2006; 20:73-83; PMID:16327322; https://doi.org/10.1097/01.aids.0000198081.09337.a7
   PubMed Web of Science ®Google Scholar
• Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, Tyring S, Aoki FY, Slaoui M, Denis M, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652-61; PMID:12444179; https://doi.org/10.1056/NEJMoa011915
   PubMed Web of Science ®Google Scholar
• Belshe RB, Leone PA, Bernstein DI, Wald A, Levin MJ, Stapleton JT, Gorfinkel I, Morrow RL, Ewell MG, Stokes-Riner A, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012; 366:34-43; PMID:22216840; https://doi.org/10.1056/NEJMicm1104023 10.1056/NEJMoa1103151
   PubMed Web of Science ®Google Scholar
• Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JM, Jr., Handsfield HH, Warren T, Marr L, Tyring S, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. Jama 1999; 282:331-40.
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barberà J, et al. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N Engl J Med 2016; 375:1019-32; PMID:27626517; https://doi.org/10.1056/NEJMoa1603800
   PubMed Web of Science ®Google Scholar
• Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, et al. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. N Engl J Med 2015; 372(22):2087-96; https://doi.org/10.1056/NEJMoa1501184 10.1056/NEJMicm1400091
   PubMed Web of Science ®Google Scholar
• Schiffer JT, Mayer BT, Fong Y, Swan DA, Wald A. Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding. J R Soc Interface 2014; 11:20140160; https://doi.org/10.1098/rsif.2014.0160
   PubMed Web of Science ®Google Scholar
• Wald A, Huang ML, Carrell D, Selke S, Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003; 188:1345-51; PMID:14593592; https://doi.org/10.1086/379043
   PubMed Web of Science ®Google Scholar
• Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770-5; PMID:7643884; https://doi.org/10.1056/NEJM199509213331205
   PubMed Web of Science ®Google Scholar
• Iwasaki A. Exploiting Mucosal Immunity for Antiviral Vaccines. Annu Rev Immunol 2016; 34:575-608; PMID:27168245; https://doi.org/10.1146/annurev-immunol-032414-112315
   PubMed Web of Science ®Google Scholar
• Awasthi S, Mahairas GG, Shaw CE, Huang ML, Koelle DM, Posavad C, Corey L, Friedman HM. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens. J Virol 2015; 89:8497-509; PMID:26041292; https://doi.org/10.1128/JVI.01089-15
   PubMed Web of Science ®Google Scholar
• Awasthi S, Balliet JW, Flynn JA, Lubinski JM, Shaw CE, DiStefano DJ, Cai M, Brown M, Smith JF, Kowalski R, et al. Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs. J Virol 2014; 88:2000-10; PMID:24284325; https://doi.org/10.1128/JVI.03163-13 10.1128/JVI.01130-14
   PubMed Web of Science ®Google Scholar